Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check16 days agoChange DetectedThe notice about government funding and NIH operating status has been removed from the page.SummaryDifference0.3%

- Check38 days agoChange DetectedMinor UI adjustments and potential timestamp changes were observed on the page; there are no alterations to core study details or purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedAdds new organizational/time context and expands IPD data sharing details while removing the previous sharing URLs and streamlined criteria.SummaryDifference11%

- Check60 days agoChange DetectedThe page now communicates an operating-status notice and that the NIH Clinical Center is open, along with where to verify status, and it updates the version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check67 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.